These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25661065)

  • 61. miR-1290 promotes IL-8-mediated vascular endothelial cell adhesion by targeting GSK-3β.
    Xu H; Cui Y; Liu X; Zheng X; Liu J; Hu X; Gao F; Hu X; Li M; Wei X; Gao Y; Zhao Y
    Mol Biol Rep; 2022 Mar; 49(3):1871-1882. PubMed ID: 34837150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma.
    Murata M; Bilim V; Shirono Y; Kazama A; Hiruma K; Tasaki M; Tomita Y
    Curr Issues Mol Biol; 2023 Sep; 45(9):7432-7448. PubMed ID: 37754254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of regulating miR-132 mediated GSK-3β on learning and memory function in mice.
    Liu G; Yin F; Zhang C; Zhang Y; Li X; Ling Y
    Exp Ther Med; 2020 Aug; 20(2):1191-1197. PubMed ID: 32742357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-939 down-regulates CD2-associated protein by targeting promoter in HEK-293T cells.
    Huang YP; Qiu LZ; Zhou GP
    Ren Fail; 2016; 38(4):508-13. PubMed ID: 26895305
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proteome and Phosphoproteome Analyses Reveal the Kinase Regulatory Network Involved in Glycogen Synthesis Kinase 3β.
    Hu M; Fang J; Wang H; Zhou S
    Front Genet; 2021; 12():657140. PubMed ID: 33897769
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dysregulated levels of glycogen synthase kinase-3β (GSK-3β) and miR-135 in peripheral blood samples of cases with nephrotic syndrome.
    Ardalan M; Hejazian SM; Sharabiyani HF; Farnood F; Ghafari Aghdam A; Bastami M; Ahmadian E; Zununi Vahed S; Cucchiarini M
    PeerJ; 2020; 8():e10377. PubMed ID: 33362958
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3β.
    Guo R; Abdelmohsen K; Morin PJ; Gorospe M
    PLoS One; 2013; 8(6):e66330. PubMed ID: 23840442
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of BMP7 on podocyte transdifferentiation and Smad7 expression induced by hyperglycemia.
    Liu L; Fu W; Xu J; Shao L; Wang Y
    Clin Nephrol; 2015 Aug; 84(2):95-9. PubMed ID: 26103965
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Corrigendum to "β-arrestin1 promotes epithelial-mesenchymal transition via modulating GSK-3β/β-catenin pathway in prostate cancer cells".
    Duan X; Zhang T; Kong Z; Mai X; Lan C; Chen D; Liu Y; Zeng Z; Cai C; Deng T; Wu W; Zeng G
    Biochem Biophys Res Commun; 2022 Nov; 628():163-165. PubMed ID: 36068090
    [No Abstract]   [Full Text] [Related]  

  • 70. Correction for: CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
    Wang J; Wen T; Li Z; Che X; Gong L; Jiao Z; Qu X; Liu Y
    Aging (Albany NY); 2022 Apr; 14(8):3720-3721. PubMed ID: 35488885
    [No Abstract]   [Full Text] [Related]  

  • 71. Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions
    Guo R; Wang P; Zheng X; Cui W; Shang J; Zhao Z
    Front Pharmacol; 2022; 13():1074294. PubMed ID: 36618948
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Studying channel and receptor physiology in podocytes.
    Ghayur MN; Janssen LJ
    Kidney Int; 2008 Feb; 73(3):364. PubMed ID: 18195704
    [No Abstract]   [Full Text] [Related]  

  • 73. GSK-3beta in mouse fibroblast controls wound healing and fibrosis through an endothelin-1-dependent mechanism.
    Kapoor M; Liu S; Shi-wen X; Huh K; McCann M; Denton CP; Woodgett JR; Abraham DJ; Leask A
    J Clin Invest; 2008 Nov; 118(11):3812. PubMed ID: 19043845
    [No Abstract]   [Full Text] [Related]  

  • 74. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
    Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
    Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Generating conditionally immortalised podocyte cell lines from wild-type mice.
    Keir LS; Firth R; May C; Ni L; Welsh GI; Saleem MA
    Nephron; 2015; 129(2):128-36. PubMed ID: 25720381
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Construction and Bioinformatics Analysis of the miRNA-mRNA Regulatory Network in Diabetic Nephropathy.
    Li Y; Xu Y; Hou Y; Li R
    J Healthc Eng; 2021; 2021():8161701. PubMed ID: 34840704
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial-Mesenchymal Transition of Podocytes by Inhibiting
    Jin J; Wang Y; Zhao L; Zou W; Tan M; He Q
    Biomed Res Int; 2020; 2020():2685305. PubMed ID: 32149094
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy.
    Shang J; Wang L; Zhang Y; Zhang S; Ning L; Zhao J; Cheng G; Liu D; Xiao J; Zhao Z
    J Cell Mol Med; 2019 May; 23(5):3417-3428. PubMed ID: 30784180
    [TBL] [Abstract][Full Text] [Related]  

  • 79. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346.
    Bai N; Peng E; Qiu X; Lyu N; Zhang Z; Tao Y; Li X; Wang Z
    J Exp Clin Cancer Res; 2018 Jul; 37(1):172. PubMed ID: 30053867
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-genetic mechanisms of diabetic nephropathy.
    Han Q; Zhu H; Chen X; Liu Z
    Front Med; 2017 Sep; 11(3):319-332. PubMed ID: 28871454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.